The DTA group will shortly be circulating updated advice to DTA review authors and MEs about these changes.
Here's more detail from the message we received today:įor authors of ongoing DTA reviews, upgrading to RevMan 5.2 will be mandatory and will feature some important changes to the tool for assessing study quality. The main changes to this version will affect Diagnostic Test Accuracy (DTA) reviews and so unlikely to affect many of our authors as we currently have no DTA reviews registered. We've today heard that RevMan 5.2 will be released this year, not RevMan 6 as previously announced.
0 kommentar(er)
